Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Funding Update

11 Nov 2015 14:26

RNS Number : 3843F
Oilex Ltd
11 November 2015
 



ASX Announcement

 

11 November 2015 WST

 

 

ASX: OEX

AIM: OEX

 

Funding - Zeta Deferred Settlement

 

Oilex Ltd (Oilex or the Company) provides an update on the deferred element of the previously announced capital raising (announcement dated 3 August 2015), being the issue of shares and convertible notes to Zeta Resources Limited (Zeta). Zeta currently has a 10.3% holding in the share capital of Oilex.

 

Pursuant to arrangements agreed with Zeta, Zeta was to subscribe for:

· A$4,243,500 of 20 year, zero coupon unsecured convertible loan notes, convertible into Oilex shares at Zeta's option at any time (subject to compliance with Australian law), at a conversion price of A$0.0418 per share, by no later than 11 November 2015 (the Convertible Notes); and

· 124,019,608 new ordinary shares at a price of A$0.0418 per share, to enable the issue of those shares to be settled by no later than 12 November 2015 (the Deferred Shares).

 

As at the date of this announcement, Zeta has failed to settle the subscription for the Convertible Notes. Oilex will be considering, together with its external legal counsel, the remedies available to it arising out of Zeta's failure to settle the Convertible Notes.

 

Zeta has alleged that the Company has failed to disclose material information to it prior to its initial investment and has contravened statutory provisions relating to misleading or deceptive conduct and continuous disclosure and rights issue disclosure requirements. Whilst Zeta has at this stage only provided limited information to the Company regarding the basis of these allegations, Oilex considers them to be without merit and they will be vigorously defended.

 

The Board of Oilex is considering the full implications and options to progress the development of the Cambay Field, as a consequence of Zeta failing to settle the subscription of the Convertible Notes.

 

 

For and on behalf of Oilex Ltd

 

 

 

Ron Miller

Managing Director

For further information, please contact:

Investor Enquiries

Oilex Ltd

Ron Miller

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

Nominated Adviser

Strand Hanson Limited

Rory Murphy/Ritchie Balmer

Email:  

oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

 

Media Enquiries

Vigo Communications

Patrick d'Ancona/Chris McMahon

Email:patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel: +44 20 7016 9570

UK

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFFFLFFISEEF
Date   Source Headline
7th Aug 20209:32 amRNSTermination of JPDA Arbitration Proceedings
31st Jul 202011:07 amRNSJune 2020 Quarterly Report
31st Jul 202010:45 amRNSLoan Restructure and Equity Issue
30th Jul 20209:00 amRNSManaging Director Contract Extension
27th Jul 20207:00 amRNSWest Kampar Update
17th Jul 20207:07 amRNSIssue of Securities
30th Jun 202010:40 amRNSSuccessful Bid for Cooper Basin Permit
30th Jun 20208:17 amRNSResults of General Meeting
30th Jun 20208:11 amRNSExecutive Director Contract Extension
30th Jun 20208:05 amRNSChange of Registered Office
29th Jun 20207:00 amRNSIndia Update
15th Jun 202010:28 amRNSChange to Notice of Meeting
15th Jun 20207:56 amRNSArmour Share Purchase Agreement
5th Jun 202011:52 amRNSExtension to Armour Agreement
3rd Jun 20201:14 pmRNSNotice of Change of Interest of Substantial Holder
1st Jun 20207:15 amRNSExtension to Armour Agreement
29th May 20207:00 amRNSNotice of General Meeting
27th May 20209:28 amRNSSale of Cooper Eromanga Basin Assets
26th May 20207:00 amRNSNotice of Change of Interest of Substantial Holder
15th May 20207:00 amRNSIssue of Securities
6th May 20207:00 amRNSAppendix 3Z B Lingo
6th May 20207:00 amRNSReplacement Appendix 5B
5th May 20208:36 amRNSBoard Changes
30th Apr 20209:16 amRNSMarch 2020 Quarterly Report
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
28th Apr 202011:02 amRNSCooper Basin Update
27th Apr 20207:14 amRNSCorrection: Variation to Financing Terms
23rd Apr 20201:45 pmRNSVariation to Financing Terms
3rd Apr 20207:00 amRNSExtension for Acquisition of Cooper Licences
3rd Apr 20207:00 amRNSChairman Consulting Contract Extension
26th Mar 20207:32 amRNSAppendix 3X Mark Bolton
26th Mar 20207:00 amRNSBoard and Executive Changes
24th Mar 20207:30 amRNSDoriemus Transaction - Update
16th Mar 20207:15 amRNSInterim Report 31 December 2019
16th Mar 20207:00 amRNSBusiness and Financial Restructure
12th Mar 20207:00 amRNSDoriemus Shareholders Approve Transaction
6th Mar 20207:15 amRNSOpportunity to Participate in Doriemus Offer
3rd Mar 202012:24 pmRNSUpdate on Cambay Sale Process
28th Feb 20209:29 amRNSExtension for Acquisition of Cooper Basin Licences
21st Feb 20207:30 amRNSStrong Funding Support for Cooper-Eromanga
11th Feb 20207:00 amRNSChairman Consulting Contract Extension
4th Feb 20207:00 amRNSAppendix 3B: Issue of Securities
3rd Feb 20202:23 pmRNSNew Series C Loan Facility
31st Jan 20208:17 amRNSDecember 2019 Quarterly Report
30th Jan 20207:00 amRNSDOR - Prop Acqn of Major Cooper-Eromanga Portfolio
29th Jan 202010:39 amRNSSale of Cooper Eromanga Basin Assets
28th Jan 20207:00 amRNSSale of Participating Interest in Bhandut
17th Jan 20202:05 pmRNSUpdate on Cambay Sale Process
7th Jan 20207:34 amRNSNotice of Change of Interest of Substantial Holder

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.